Partnerships have been playing an integral role in Nicox’s growth and Nicox has demonstrated its expertise in managing successful alliances with both leading pharmaceutical companies and biotechs internationally.
Partnerships accelerate the advancement of Nicox’s research and development activities, in particular in non-core areas, allow us to share and build our expertise and endorse the company’s nitric oxide-donating research platform.
To support its growth in the ophthalmic field, Nicox is now looking for additional development assets. We are seeking potential in-licensing or acquisition in ophthalmic and therapeutics to enhance our innovative pipeline.
We are always interested in hearing about potential collaborations; do not hesitate to contact us if you share our passion for visible science.